Jump to content

Cerebral salt-wasting syndrome: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
Line 24: Line 24:


==Treatment==
==Treatment==
While CSWS usually appears within the first week after brain injury and spontaneously resolves in 2–4 weeks, it can sometimes last for months, years, or a lifetime. While fluid restriction is used to treat SIADH, CSWS requires aggressive hydration and correction of the low sodium levels using sodium chloride tablets. Sometimes, [[fludrocortisone]] (a [[mineralocorticoid]]) improves the hyponatremia.<ref name="pmid11836078">{{cite journal |author=Betjes MG |title=Hyponatremia in acute brain disease: the cerebral salt wasting syndrome |journal=Eur J Intern Med |volume=13 |issue=1 |pages=9–14 |year=2002 |pmid=11836078 |doi= 10.1016/S0953-6205(01)00192-3|url=http://linkinghub.elsevier.com/retrieve/pii/S0953620501001923}}</ref>
While CSWS usually appears within the first week after brain injury and spontaneously resolves in 2–4 weeks, it can sometimes last for months or years. While fluid restriction is used to treat SIADH, CSWS requires aggressive hydration and correction of the low sodium levels using sodium chloride tablets. Sometimes, [[fludrocortisone]] (a [[mineralocorticoid]]) improves the hyponatremia.<ref name="pmid11836078">{{cite journal |author=Betjes MG |title=Hyponatremia in acute brain disease: the cerebral salt wasting syndrome |journal=Eur J Intern Med |volume=13 |issue=1 |pages=9–14 |year=2002 |pmid=11836078 |doi= 10.1016/S0953-6205(01)00192-3|url=http://linkinghub.elsevier.com/retrieve/pii/S0953620501001923}}</ref>


==References==
==References==

Revision as of 02:57, 26 April 2010

Cerebral salt-wasting syndrome

Cerebral salt-wasting syndrome (CSWS) is a rare endocrine condition featuring hyponatremia (low blood sodium levels) and dehydration in response to trauma/injury or the presence of tumors in or surrounding the brain. This form of hyponatraemia is due to excessive renal sodium excretion resulting from a centrally mediated process.

The condition was initially described in 1950.[1]

Symptoms

Primary symptoms include polyuria (at least 2.5 liters in the course of 24 hours, for adults) due to inadequate sodium retention in the body, polydipsia (excessive thirst) due to polyuria, extreme salt cravings (e.g. desire to drink pickle juice), dysautonomia, and dehydration. Patients often "self-medicate" by naturally gravitating toward a high-sodium diet and by dramatically increasing their water intake. Advanced symptoms include muscle cramps, lightheadedness, dizziness or vertigo, feelings of anxiety or panic (not mentally induced), tachycardia (rapid heart rate) or bradycardia (slow heart rate), hypotension and orthostatic hypotension sometimes resulting in syncope.[2] Other symptoms frequently associated with dysautonomia include: headaches, pallor, malaise, facial flushing, constipation or diarrhea, nausea, acid reflux, visual disturbances, numbness, nerve pain, trouble breathing, chest pains, loss of consciousness and seizures.[2]

Causes and Diagnosis

CSWS is usually caused by brain injury/trauma or cerebral lesion, tumor, or hematoma. CSWS is a diagnosis of exclusion and may be difficult to distinguish from the syndrome of inappropriate antidiuretic hormone (SIADH), which develops under similar circumstances and also presents with hyponatremia. The main clinical difference is that of total fluid status of the patient: CSWS leads to a relative or overt hypovolemia whereas SIADH is consistent with a normal to hypervolemic range. Random urine sodium concentrations tend to be lower than 100 mEq/L in CSWS and greater in SIADH . If blood-sodium levels increase when fluids are restricted, SIADH is more likely. [3]

Treatment

While CSWS usually appears within the first week after brain injury and spontaneously resolves in 2–4 weeks, it can sometimes last for months or years. While fluid restriction is used to treat SIADH, CSWS requires aggressive hydration and correction of the low sodium levels using sodium chloride tablets. Sometimes, fludrocortisone (a mineralocorticoid) improves the hyponatremia.[4]

References

  1. ^ Peters JP, Welt LG, Sims EA, Orloff J, Needham J (1950). "A salt-wasting syndrome associated with cerebral disease". Trans. Assoc. Am. Physicians. 63: 57–64. PMID 14855556.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  2. ^ a b Tierney, Lawrence M.; McPhee, Stephen J.; Papadakis, Maxine A. (2006). Current Medical Diagnosis and Treatment 2007 (Current Medical Diagnosis and Treatment). McGraw-Hill Professional. p. 1010. ISBN 0-07-147247-9.{{cite book}}: CS1 maint: multiple names: authors list (link)
  3. ^ Harrigan MR (1996). "Cerebral salt wasting syndrome: a review". Neurosurgery. 38 (1): 152–60. doi:10.1097/00006123-199601000-00035. PMID 8747964.
  4. ^ Betjes MG (2002). "Hyponatremia in acute brain disease: the cerebral salt wasting syndrome". Eur J Intern Med. 13 (1): 9–14. doi:10.1016/S0953-6205(01)00192-3. PMID 11836078.

This template is no longer used; please see Template:Endocrine pathology for a suitable replacement